1. The Unaudited Standalone Financial Results of the Company for the Second Quarter and half year ended 30th September 2025 along with Statutory Auditors Limited Review Report thereon.
Awaiting price reaction for this filing.
Clenon Enterprises reported a steep decline in Q2 FY26, with revenue from operations falling to ₹48.67 lakh from ₹138.74 lakh a year ago, and total income at ₹49.45 lakh versus ₹195.71 lakh (the previous year included a one-time ₹195.71 lakh gain from sale of land). The company swung to a loss of ₹58.90 lakh in Q2 from a profit of ₹127.44 lakh, resulting in a half-year loss of ₹120.28 lakh and a basic loss per share of ₹1.40. Other equity has eroded further to negative ₹250.79 lakh, while borrowings stand at ₹778.36 lakh against total equity of ₹610.74 lakh. Operating cash flow was negative at ₹25.81 lakh for the half year. Separately, the board approved issuing up to 25 lakh equity shares (face value ₹10) on a preferential basis to strategic investors, pursuant to the NCLT-approved Resolution Plan from March 2023. The auditor (Gorantla & Co) issued an unmodified limited review report.
Shareholders face continued losses, a weakened balance sheet with negative other equity and debt exceeding equity, and potential dilution from the preferential issue, though the capital infusion is aimed at reviving operations under the NCLT resolution plan.